简体中文 | 繁體中文 | English

Health and Pharmaceutical Press Releases

2024-12-13 14:41 Tanner Pharma Expands Global Access to Botensilimab and Balstilimab Through Partnership With Agenus
2024-12-13 14:24 CHMP Recommends Approval of Galderma’s Nemolizumab for Moderate-to-Severe Atopic Dermatitis and Prurigo Nodularis in the European Union
2024-12-13 13:23 Orthogon Therapeutics Closes Oversubscribed $5.2M Financing to Advance First Oral Therapy for BK Polyomavirus
2024-12-13 10:34 Takeda Spotlights High-Value, Late-Stage Pipeline Accelerating the Development of Potential Transformative Treatments for Patients in Multiple Therapeutic Areas
2024-12-13 10:17 PHC Live Cell Metabolic Analyzer (LiCellMo) Receives 2024 Innovation Award from The Analytical Scientist
2024-12-11 13:19 BeiGene Advances Leadership in CLL at ASH 2024 with New Data From Its Hematology Franchise Including BRUKINSA® and Novel Pipeline Assets
2024-12-06 17:52 APRIL Group Continues Its International Expansion by Strengthening Its Presence in China
2024-12-06 17:28 Rigaku Announces XSPA-200 ER Detector for X-ray Diffraction System
2024-12-06 11:25 Vevo Therapeutics Partners with the Parse Biosciences GigaLab to Generate 100M Cell Atlas for AI Powered Drug Discovery
2024-12-05 10:23 Nurse Maria Victoria Juan From Philippines Wins the Prestigious Aster Guardians Global Nursing Award 2024
2024-12-05 09:51 Kalyra Elevates Aged Care Experience With Boomi Integration
2024-12-04 12:51 Avania Appoints Innovative Operations Strategist Charlene Dark as New Chief Operating Officer
2024-12-04 10:07 Takeda Strengthens Oncology Pipeline with Elritercept through Licensing Agreement with Keros Therapeutics
2024-12-02 12:56 GE HealthCare to Acquire Remaining 50% Stake in Nihon Medi-Physics (NMP), a Leading Radiopharmaceutical Company in Japan, from Sumitomo Chemical
2024-11-28 14:04 Galderma’s Phase III OLYMPIA 1 Data Published in JAMA Dermatology Demonstrate That Nemolizumab Improves Core Signs and Symptoms of Prurigo Nodularis
2024-11-28 11:42 U.S. FDA Approves AOP Health’s RapiblykTM (landiolol) for Atrial Fibrillation and Atrial Flutter in the Critical Care Setting
2024-11-27 11:27 Viromed Medical AG: Cold Plasma as a Digital Antibiotic for the Lungs
2024-11-26 16:22 Kolmar BNH Revolutionizes ESG with HemoHIM, an Eco-friendly Health Supplement
2024-11-25 11:39 TA Announces Strategic Investment in Vee Healthtek to Support Continued Growth and Innovation
2024-11-25 11:00 Novotech Publishes Comprehensive Report on the Global Vaccine Clinical Trials Landscape

Business Wire Weibo

Press Releases

Latest Releases